Brain rust: Recent discoveries on the role of oxidative stress in neurodegenerative diseases

Nutritional Neuroscience

Volumn 15, Issue 3, 2012, Pages 94-102

  de Oliveira, Diêgo Madureira ^a   Lima, Rute Maria Ferreira ^a   El Bachá, Ramon Santos ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Alzheimer's disease; Mitochondria; Neurodegenerative diseases; Oxidative stress; Parkinson's disease

Indexed keywords

BIOCHEMICAL MARKER; CALCIUM; GLUCOCORTICOID; HEAT SHOCK PROTEIN; INSULIN; TRACE METAL;

BRAIN DEGENERATION; BRAIN MITOCHONDRION; CELL CYCLE REGULATION; DEGENERATIVE DISEASE; ENDOPLASMIC RETICULUM STRESS; EVIDENCE BASED MEDICINE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENOTYPE ENVIRONMENT INTERACTION; GOLGI COMPLEX; HUMAN; IN VIVO STUDY; INTRACELLULAR SIGNALING; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NONHUMAN; NUTRITIONAL ASSESSMENT; OXIDATION KINETICS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SENSITIVITY AND SPECIFICITY;

AGING; ANIMALS; ANTIOXIDANTS; BRAIN; HUMANS; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; PREVALENCE; REACTIVE OXYGEN SPECIES;

EID: 84862601037     PISSN: 1028415X     EISSN: 14768305     Source Type: Journal    
DOI: 10.1179/1476830511Y.0000000029     Document Type: Review

References (83)

1. Fahn S, Sulzer D. Neurodegeneration and neuroprotection in Parkinson disease. Neurotherapeutics 2004;1:139-54.
2. Roos RAC. Huntington's disease: a clinical review. Orphanet J Rare Dis 2010;5:40-7.
3. Pinholster G. Alzheimer's experts share diverse insights on disease. Science 2011;332:553.
4. Irizarry MC. Biomarkers of Alzheimer disease in plasma. Neurotherapeutics 2004;1:226-34.
5. Shang F, Taylor A. Ubiquitin-proteasome pathway and cellular responses to oxidative stress. Free Radic Biol Med 2011;51:5-16.
6. Halliwell B. Reactive species and antioxidants. Redox biology is a fundamental theme of aerobic life. Plant Physiol 2006;141: 312-22.
7. Conklin KA. Dietary polyunsaturated fatty acids: impact on cancer chemotherapy and radiation. Altern Med Rev 2002;7: 4-21.
8. Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer 2011;11:85-95.
9. Ristow M, Schmeisser S. Extending life span by increasing oxidative stress. Free Radic Biol Med 2011;51:327-36.
10. Serra S. Hormese. Rev DERC 2011;17:8-9.
11. Mattei R, Polotow TG, Vardaris CV, Guerra BA, Leite JR, Otton R, et al. Astaxanthin limits fish oil-related oxidative insult in the anterior forebrain of Wistar rats: putative anxiolytic effects? Pharmacol Biochem Behav 2011;99:349-55.
12. Mastroeni D, Grover A, Delvaux E, Whiteside C, Coleman PD, Rogers J. Epigenetic mechanisms in Alzheimer's disease. Neurobiol Aging 2011;32:1161-80.
13. Balazs R, Vernon J, Hardy J. Epigenetic mechanisms in Alzheimer's disease: progress but much to do. Neurobiol Aging 2011;32:1181-7.
14. Lee MJ, Park SH, Han JH, Hong YK, Hwang S, Lee S, et al. The effects of hempseed meal intake and linoleic acid on Drosophila models of neurodegenerative diseases and hypercholesterolemia. Mol Cells 2011;31:337-42.
15. Lebel M, Picard F, Ferland G, Gaudreau P. Drugs, nutrients, and phytoactive principles improving the health span of rodent models of human age-related diseases. J Gerontol A Biol Sci Med Sci 2011; doi:10.1093/gerona/glr038.
16. Bayir H, Kagan VE. Bench-to-bedside review: mitochondrial injury, oxidative stress and apoptosis there is nothing more practical than a good theory. Crit Care 2008;12:206-15.
17. Avery SV. Molecular targets of oxidative stress. Biochem J 2011; 434:201-10.
18. Sai T, Uchida K, Nakayama H. Acute toxicity of MPTP and MPP+ in the brain of embryo and newborn mice. Exp Toxicol Pathol 2011; In Press. doi:10.1016/j.etp.2011.06.008.
19. Kwon HJ, Heo JY, Shim JH, Park JH, Seo KS, Ryu MJ, et al. DJ-1 mediates paraquat-induced dopaminergic neuronal cell death. Toxicol Lett 2011;202:85-92.
20. Ulusoy GK, Celik T, Kayir H, Gürsoy M, Isik AT, Uzbay TI. Effects of pioglitazone and retinoic acid in a rotenone model of Parkinson's disease. Brain Res Bull 2011;85:380-4.
21. Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J. Epidemiology and etiology of Parkinson's disease: a review of the evidence. Eur J Epidemiol 2011;26:S1-58.
22. Silva-Adaya D, Pérez-De La Cruz V, Herrera-Mundo MN, Mendoza-Macedo K, Villeda-Hernández J, Binienda Z, et al. Excitotoxic damage, disrupted energy metabolism, and oxidative stress in the rat brain: antioxidant and neuroprotective effects of L-carnitine. J Neurochem 2008;105:677-89.
23. Pereira MRG, de Oliveira ES, de Villar FAGA, Grangeiro MS, Fonseca J, Silva AR, et al. Cytotoxicity of catechol towards human glioblastoma cells via superoxide and reactive quinones generation. J Bras Patol Med Lab 2004;40:280-5.
24. Lima RMF, Alvarez LDG, Costa MFD, Costa SL, Clarêncio J, El-Bachá RS. Cytotoxic effects of catechol to neuroblastoma N2a cells. Gen Physiol Biophys 2008;27:306-14.
25. de Oliveira DM, Pitanga BPS, Grangeiro MS, Lima RMF, Costa MFD, Costa SL, et al. Catechol cytotoxicity in vitro: induction of glioblastoma cell death by apoptosis. Hum Exp Toxicol 2010; 29:199-212.
26. Napolitano A, Manini P, d'Ischia M. Oxidation chemistry of catecholamines and neuronal degeneration: an update. Curr Med Chem 2011;18:1832-45.
27. El-Bachá RS, Netter P, Minn A. Mechanisms of apomorphine cytoxicity towards rat glioma C6 cells: protection by bovine serum albumin and formation of apomorphine-protein conjugates. Neurosci Lett 1999;263:25-8.
28. El-Bachá RS, Leclerc S, Netter P, Magdalou J, Minn A. Glucuronidation of apomorphine. Life Sci 2000;67:1735-45.
29. Jomova K, Valko M. Advances in metal-induced oxidative stress and human disease. Toxicology 2011;283:65-87.
30. Spencer WA, Jeyabalan J, Kichambre S, Gupta RC. Oxidatively generated DNA damage after Cu(II) catalysis of dopamine and related catecholamine neurotransmitters and neurotoxins: role of reactive oxygen species. Free Radic Biol Med 2011;50: 139-47.
31. Murray IVJ, Sindoni ME, Axelsen PH. Promotion of oxidative lipid membrane damage by amyloid beta proteins. Biochemistry 2005;44:12606-13.
32. 2+ complexes in both monomeric and fibrillar forms do not generate H2O2 catalytically but quench hydroxyl radicals. Biochemistry 2008;47: 11653-64.
33. Barnham KJ, Bush AI. Metals in Alzheimer's and Parkinson's diseases. Curr Opin Chem Biol 2008;12:222-28.
34. Lee SJ, Koh JY. Roles of zinc and metallothionein-3 in oxidative stress-induced lysosomal dysfunction, cell death, and autophagy in neurons and astrocytes. Mol Brain 2010;3:30-8.
35. Salvador GA, Oteiza PI. Iron overload triggers redox-sensitive signals in human IMR-32 neuroblastoma cells. Neurotoxicology 2011;32:75-82.
36. Nishida Y. The chemical process of oxidative stress by copper(II) and iron(III) ions in several neurodegenerative disorders. Monatsh Chem 2011;142:375-84.
37. Butterfield DA, Abdul HM, Newman S, Reed T. Redox proteomics in some age-related neurodegenerative disorders or models thereof. Neurotherapeutics 2006;3:344-57.
38. Kalmar B, Greensmith L. Induction of heat shock proteins for protection against oxidative stress. Adv Drug Deliv Rev 2009; 61:310-8.
39. Jiang Z, Hu Z, Zeng L, Lu W, Zhang H, Li T, et al. The role of the Golgi apparatus in oxidative stress: is this organelle less significant than mitochondria? Free Radic Biol Med 2011;50:907-17.
40. Calì T, Ottolini D, Brini M. Mitochondria, calcium, and endoplasmic reticulum stress in Parkinson's disease. Biofactors 2011;37:228-40.
41. Anazetti MC, Melo PS. Morte celular por apoptose: uma visão bioquímica e molecular. Metrocamp Pesq 2007;1:37-58.
42. Tabas I, Ron D. Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat Cell Biol 2011;13:184-90.
43. Calabrese V, Cornelius C, Mancuso C, Lentile R, Stella AM, Butterfield DA. Redox homeostasis and cellular stress response in aging and neurodegeneration. Methods Mol Biol 2010;610: 285-308.
44. Jiang B, Liang P, Deng G, Tu Z, Liu M, Xiao X. Increased stability of Bcl-2 in HSP70-mediated protection against apoptosis induced by oxidative stress. Cell Stress Chaperones 2011;16: 143-52.
45. Montine TJ, Woltjer RL, Pan C, Montine KS, Zhang J. Liquid chromatography with tandem mass spectrometry-based proteomic discovery in aging and Alzheimer's disease. Neurotherapeutics 2006;3:336-43.
46. Jeppesen DK, Bohr VA, Stevnsner T. DNA repair deficiency in neurodegeneration. Prog Neurobiol. 2011;94:166-200.
47. Fuso A, Scarpa S. One-carbon metabolism and Alzheimer's disease: is it all a methylation matter? Neurobiol Aging 2011; 32:1192-5.
48. Hernández-Ortega K, Quiroz-Baez R, Arias C. Cell cycle reactivation in mature neurons: a link with brain plasticity, neuneuronal injury and neurodegenerative diseases? Neurosci Bull 2011; 27:185-96.
49. Bleackley MR, MacGillivray RTA. Transition metal homeostasis: from yeast to human disease. Biometals 2011;24:785-809.
50. Pankratz N, Foroud T. Genetics of Parkinson disease. Neurotherapeutics 2004;1:235-42.
51. Keyser RJ, Oppon E, Carr JA, Bardien S. Identification of Parkinson's disease candidate genes using CAESAR and screening of MAPT and SNCAIP in South African Parkinson's disease patients. J Neural Transm 2011;118:889-97.
52. von Otter M, Ladgren S, Nilsson S, Celojevic D, Bergström P, Håkansson A, et al. Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease. BMC Med Genet 2010;11: 36-45.
53. Stepkowski TM, Kruszewski MK. Molecular cross-talk between the NRF2/KEAP1 signaling pathway, autophagy, and apoptosis. Free Radic Biol Med 2011;50:1186-95.
54. Khoshnan A, Patterson PH. The role of IκB kinase complex in the neurobiology of Huntington's disease. Neurobiol Dis 2011; 43:305-11.
55. Kim S-J, Zhang Z, Saha A, Sarkar C, Zhao Z, Xu Y, et al. Omega-3 and omega-6 fatty acids suppress ER-and oxidative stress in cultured neurons and neuronal progenitor cells from mice lacking PPT1. Neurosci Lett 2010;479:292-6.
56. Grammas P, Martinez J, Miller B. Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases. Exp Rev Mol Med 2011;13:1-22.
57. Manczak M, Mao P, Calkins MJ, Cornea A, Reddy AP, Murphy MP, et al. Mitochondria-targeted antioxidants protect against amyloid-β toxicity in Alzheimer's disease neurons. J Alzheimers Dis 2010;20(Suppl 2):609-31.
58. Xie W, Wan OW, Chung KKK. New insights into the role of mitochondrial dysfunction and protein aggregation in Parkinson's disease. Biochim Biophys Acta 2010;1802:935-41.
59. Long J, Liu C, Sun L, Gao H, Liu J. Neuronal mitochondrial toxicity of malondialdehyde: inhibitory effects on respiratory function and enzyme activities in rat. Neurochem Res 2009;34: 786-94.
60. Wen Y, Poteet EC, Xie L, Tan C, Yan L-J, Ju X, et al. Alternative mitochondrial electron transfer as a novel strategy for neuroprotection. J Biol Chem 2011;286:16504-15.
61. Bisaglia M, Soriano ME, Arduini I, Mammi S, Bubacco L. Molecular characterization of dopamine-derived quinones reactivity toward NADH and glutathione: implications for mitochondrial dysfunction in Parkinson disease. Biochim Biophys Acta 2010;1802:699-706.
62. Stone TW, Forrest CM, Stoy N, Darlington LG. Involvement of kynurenines in Huntington's disease and stroke-induced brain damage. J Neural Transm 2012;119:261-74.
63. Pinheiro AM, Costa SL, Freire SM, Meyer R, Almeida MAO, Tardy M, et al. Neospora caninum: infection induced IL-10 over-expression in rat astrocytes in vitro. Exp Parasitol 2006;112: 193-7.
64. Silva AMM, Silva AR, Pinheiro AM, Freitas SRVB, Silva VDA, Souza CS, et al. Alkaloids from Prosopis juliflora leaves induce glial activation, cytotoxicity and stimulate NO production. Toxicon 2007;49:601-14.
65. +-induced mitochondrial dysfunction and ROS production in vivo and in vitro. Food Chem Toxicol 2011;49: 271-80.
66. Kourtis N, Tavernarakis N. Cellular stress response pathways and ageing: intricate molecular relationships. EMBO J 2011; 30:2520-31.
67. Shaerzadeh F, Ahmadiani A, Esmaeili MA, Ansari N, Asadi S, Tusi SK, et al. Antioxidant and antiglycating activities of Salvia sahendica and its protective effect against oxidative stress in neuron-like PC12 cells. J Nat Med 2011;65:455-65.
68. El-Bachá RS, de-Lima-Filho JL, Guedes RCA. Dietary antioxidant deficiency facilitates cortical spreading depression induced by photoactivated riboflavin. Nutr Neurosci 1998;1:205-12.
69. Seet RCS, Lee C-YJ, Loke WM, Huang SH, Huang H, Looi WF, et al. Biomarkers of oxidative damage in cigarette smokers: which biomarkers might reflect acute versus chronic oxidative stress? Free Radic Biol Med 2011;50:1787-93.
70. Cummings JL. Biomarkers in Alzheimer's disease drug development. Alzheimer's Dementia 2011;7:e13-e44.
71. Baillet A, Chanteperdrix V, Trocmé C, Casez P, Garrel C, Besson G. The role of oxidative stress in amyotrophic lateral sclerosis and Parkinson's disease. Neurochem Res 2010;35:1530-7.
72. Mythri RB, Venkateshappa C, Harish G, Mahadevan A, Muthane UB, Yasha TC, et al. Evaluation of markers of oxidative stress, antioxidant function and astrocytic proliferation in the striatum and frontal cortex of Parkinson's disease brains. Neurochem Res 2011;36:1452-63.
73. O'Brien JT, Burns A, Ashley P, Bullock R, Burn D, Holmes C, et al. Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology. J Psychopharmacol 2011;25:997-1019.
74. Conrad M, Sato H. The oxidative stress-inducible cystine/glutamate antiporter, system xc-: cystine supplier and beyond. Amino Acids 2012;42:231-46.
75. Kim M-J, Lee J, Seong A-R, Lee Y-H, Kim Y-J, Baek H-Y, et al. Neuroprotective effects of Eriobotrya japonica against β-amyloid-induced oxidative stress and memory impairment. Food Chem Toxicol 2011;49:780-4.
76. Miyake Y, Tanaka K, Fukushima W, Sasaki S, Kiyohara C, Tsuboi Y, et al. Dietary intake of metals and risk of Parkinson's disease: a case-control study in Japan. J Neurol Sci 2011;306:98-102.
77. Schmidt S, Linnartz B, Medritzki S, Sczepan T, Lübbert M, Stichel CC, et al. Genetic mouse models for Parkinson's disease display severe pathology in glial cell mitochondria. Hum Mol Genet 2011;20:1197-211.
78. Snow BJ, Rolfe FL, Lockhart MM, Frampton CM, O'Sullivan JD, Fung V, et al. A double-blind, placebo-controlled study toassess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease. Mov Dis 2010;25:1670-4.
79. Kaur H, Chauhan S, Sandhir R. Protective effect of lycopene on oxidative stress and cognitive decline in rotenone induced model of Parkinson's disease. Neurochem Res 2011; 36:1435-43.
80. Costantini D, Marasco V, Møller AP. A meta-analysis of glucocorticoids as modulators of oxidative stress in vertebrates. J Comp Physiol B 2011;181:447-56.
81. Yu S, Feng Y, Shen Z, Li M. Diet supplementation with iron augments brain oxidative stress status in a rat model of psychological stress. Nutrition 2011;27:1048-52.
82. Martín S, González-Burgos E, Carretero ME, Gómez-Serranillos MP. Neuroprotective properties of Spanish red wine and its isolated polyphenols on astrocytes. Food Chem 2011; 128:40-8.
83. Morillas-Ruiz JM, Rubio-Perez JM, Albaladejo MD, Zafrilla P, Parra S, Vidal-Guevara ML. Effect of an antioxidant drink on homocysteine levels in Alzheimer's patients. J Neurol Sci 2010; 299:175-8.